Drugs / Stem cells administered to participants
last change Mar 2022 re-read 3 minutes ago

Stem cells administered to participants

Developed for
congestive heart failure · myocardial infarction
Investigated by
CellBank of Japan · Sakakibara Heart Institute

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03351400 Nov 2017 → Mar 2022 congestive heart failure, myocardial infarction Sakakibara Heart Institute Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Stem cells administered to participants ClinicalTrials.gov intervention name — accepted as the source's own label NCT03351400 ↗